Skip to content

13F-HR filed by Omega Fund Management, LLC

Omega Fund Management, LLC filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-14, with 11 holding rows worth $160,008,732.

Accession
0000950123-24-011486
Filed
2024-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2024

A holdings report, 11 entries on the cover page, a total value of $160,008,732 stated on the cover page (in dollars after the unit check, H1), rows summing to $160,008,733 with VALUE read as dollars as filed, 13F file number 028-16844. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BICARA THERAPEUTICS INC055477103COM2,204,650$56,152,436dollars as filed
NUVATION BIO INC COM CL A67080N101Stock13,072,340$29,935,659dollars as filed
REPLIMUNE GROUP INC76029N106COMMON STOCK2,461,319$26,976,056dollars as filed
LEXEO THERAPEUTICS INC52886X107COMMON STOCK2,355,904$21,297,372dollars as filed
ENGENE HOLDINGS INC29286M105COM1,076,357$7,103,956dollars as filed
ALUMIS INC022307102COM653,223$6,976,422dollars as filed
IKENA ONCOLOGY INC45175G108COM2,249,123$3,890,983dollars as filed
SANA BIOTECHNOLOGY INC799566104COM843,750$3,510,000dollars as filed
IMMUNIC INC4525EP101COM1,788,160$2,950,464dollars as filed
ENGENE HOLDINGS INC29286M113W EXP 10/31/2028321,502$675,154dollars as filed
SYROS PHARMACEUTICALS INC87184Q206COM NEW251,270$540,231dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-24-011486this filing2024-11-14acceptance time not in the bulk data set